- ICH GCP
- Registro de ensayos clínicos de EE. UU.
- Ensayo clínico NCT00567294
Evaluating Ways to Improve Medication Use Among People With Osteoporosis
Improving Medication Adherence for Osteoporosis: A Community-Based Randomized Controlled Trial
Descripción general del estudio
Estado
Condiciones
Descripción detallada
Fractures associated with osteoporosis are expected to rise to 3 million by 2025 with a cost of $25 billion in medical costs. Many of these fractures could be avoided through preventive measures, such as improved implementation of fall reduction strategies and use of effective medications. While medications can significantly reduce the chance of fractures among adults with osteoporosis, alarmingly few at-risk adults use osteoporosis treatments regularly. Only 10% to 30% of at-risk adults ever initiate osteoporosis medications, and of those, only 40% to 50% continue to fill their prescriptions after 1 year. There is a clear need to develop ways for improving adherence with osteoporosis medication regimens. The purpose of this study is to evaluate a telephone coaching program, with or without helpful adherence notifications to doctors, in improving treatment adherence in older adults who are starting an osteoporosis medication.
Participation in this study will last 1 year. Through random assignment of doctor practices, participants will fall into one of three groups.
- Group A participants will receive mailed education materials on osteoporosis and medication use throughout the 1-year study.
- Group B participants will receive monthly 5- to 10-minute phone calls from a health educator who is specially trained in osteoporosis. The phone calls will involve coaching participants on behavioral reinforcement strategies that will help them to continue taking their medications on schedule. Participants will also receive specially tailored education on osteoporosis and fracture prevention during the phone calls. A close family member or friend of the participant will be contacted via phone two times during the study year. During these phone calls, the family member or friend will learn how to support the participant in such a way that medication adherence is more likely.
- Group C participants will receive the same treatment as Group B. Doctors assigned to Group C will receive written educational information on the rates of medication adherence, implications of nonadherence, and methods for improving adherence among patients. Doctors will also receive alerts about any of their participating patients who are not filling medication prescriptions. The alert message will be provided in both paper and electronic format. The electronic format can be easily formatted, allowing the doctor to send a personalized letter to their patients.
At the end of the study, all participants will complete a mailed questionnaire on their behaviors and demographics. Doctors will complete a mailed questionnaire aimed at determining what parts of the interventions were well received. The occurrence of hip, forearm, and/or upper arm fractures will be evaluated using Medicare claims data.
Tipo de estudio
Inscripción (Actual)
Fase
- Fase 3
Contactos y Ubicaciones
Ubicaciones de estudio
-
-
Massachusetts
-
Boston, Massachusetts, Estados Unidos, 02115
- Brigham and Women's Hospital
-
-
Criterios de participación
Criterio de elegibilidad
Edades elegibles para estudiar
Acepta Voluntarios Saludables
Géneros elegibles para el estudio
Descripción
Inclusion Criteria:
- Patients enrolled in the Pharmaceutical Assistance Contract for the Elderly (PACE) program at the Pennsylvania Department of Aging who begin taking a medication for osteoporosis
Exclusion Criteria:
- Unable to communicate over the telephone with health educators
Plan de estudios
¿Cómo está diseñado el estudio?
Detalles de diseño
- Propósito principal: Tratamiento
- Asignación: Aleatorizado
- Modelo Intervencionista: Asignación paralela
- Enmascaramiento: Ninguno (etiqueta abierta)
Armas e Intervenciones
Grupo de participantes/brazo |
Intervención / Tratamiento |
|---|---|
|
Comparador activo: A
Participants will receive mailed education materials on osteoporosis and medication use.
|
Mailed education materials on osteoporosis and medication use over a 1-year period
|
|
Experimental: B
Participants will receive a telephone coaching program.
|
A telephone coaching program that will involve twelve monthly 5- to 10-minute phone calls from a health educator who is specially trained in osteoporosis.
The phone calls will involve coaching participants on behavioral reinforcement strategies that will help them to continue taking their medications on schedule; phone calls will also include specially tailored education on osteoporosis and fracture prevention.
A close family member or friend of the participant will also be contacted via phone two times during the study by the health educator.
During these phone calls, the family member or friend will learn how to support the participant in such a way that medication adherence is more likely.
|
|
Experimental: C
Participants will receive a telephone coaching program, and doctors of these participants will receive medication adherence alert notifications.
|
A telephone coaching program that will involve twelve monthly 5- to 10-minute phone calls from a health educator who is specially trained in osteoporosis.
The phone calls will involve coaching participants on behavioral reinforcement strategies that will help them to continue taking their medications on schedule; phone calls will also include specially tailored education on osteoporosis and fracture prevention.
A close family member or friend of the participant will also be contacted via phone two times during the study by the health educator.
During these phone calls, the family member or friend will learn how to support the participant in such a way that medication adherence is more likely.
Doctors of participants will receive written educational information on the rates of medication adherence, implications of nonadherence, and methods for improving adherence among people with osteoporosis.
Doctors will also receive alerts on any patients who are not filling their medication prescriptions.
|
¿Qué mide el estudio?
Medidas de resultado primarias
Medida de resultado |
Periodo de tiempo |
|---|---|
|
Medication adherence
Periodo de tiempo: At Month 12
|
At Month 12
|
Medidas de resultado secundarias
Medida de resultado |
Periodo de tiempo |
|---|---|
|
Medication persistence
Periodo de tiempo: At Month 12
|
At Month 12
|
Colaboradores e Investigadores
Patrocinador
Investigadores
- Investigador principal: Daniel H. Solomon, MD, MPH, Brigham and Women's Hospital
- Director de estudio: Timothy Gleeson, BS, Brigham and Women's Hospital
Publicaciones y enlaces útiles
Fechas de registro del estudio
Fechas importantes del estudio
Inicio del estudio
Finalización primaria (Actual)
Finalización del estudio (Actual)
Fechas de registro del estudio
Enviado por primera vez
Primero enviado que cumplió con los criterios de control de calidad
Publicado por primera vez (Estimar)
Actualizaciones de registros de estudio
Última actualización publicada (Estimar)
Última actualización enviada que cumplió con los criterios de control de calidad
Última verificación
Más información
Términos relacionados con este estudio
Términos MeSH relevantes adicionales
Otros números de identificación del estudio
- P60AR047782 (Subvención/contrato del NIH de EE. UU.)
- P60AR047782-06A1 (Subvención/contrato del NIH de EE. UU.)
Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .
Ensayos clínicos sobre Osteoporosis
-
Radius Health, Inc.TerminadoOsteoporosis | Riesgo de osteoporosis | Osteoporosis Posmenopáusica | Fractura de osteoporosis | Osteoporosis relacionada con la edad | Osteoporosis localizada en la columna vertebral | Osteoporosis senil | Osteoporosis de vértebras | Osteoporosis VertebralEstados Unidos
-
Appalachian State UniversityNorth Carolina Agriculture & Technical State UniversityTerminadoOsteoporosis posmenopáusica | Osteoporosis, OsteopeniaEstados Unidos
-
National Taiwan University HospitalNational Taiwan UniversityAún no reclutandoOsteoporosis | Osteoporosis posmenopáusica | Osteopenia posmenopáusica | Osteoporosis PrimariaTaiwán
-
mAbxience Research S.L.TerminadoMujeres posmenopáusicas con osteoporosisPolonia, Serbia, Bulgaria, Georgia, Estonia, Hungría, Letonia, México
-
AmgenTerminadoOsteoporosis posmenopáusica (OPM)Japón
-
Istanbul Physical Medicine Rehabilitation Training...ReclutamientoOsteoporosis posmenopáusicaTurquía (Türkiye)
-
Deltanoid PharmaceuticalsTerminadoOsteoporosis posmenopáusica, sitios múltiples
-
Riphah International UniversityAún no reclutandoOsteoporosis posmenopáusicaPakistán
-
Marmara UniversityAún no reclutandoOsteoporosis en mujeres posmenopáusicasPavo
-
Radius Health, Inc.TerminadoOsteoporosis | Osteoporosis relacionada con la edad | Osteoporosis relacionada con la edad | Osteoporosis localizada en la columna vertebral | Osteoporosis senil | Osteoporosis de vértebrasEstados Unidos, Polonia, Italia
Ensayos clínicos sobre Mailed education
-
Tarsus UniversityTerminadoEducación EnfermeríaPavo
-
Chia-Tzu LineTerminadoDiabetes mellitus tipo 2 (DM2) | Pacientes diabéticos, autocuidado, basada en inteligencia artificial, autoeficaciaPorcelana
-
State University of New York at BuffaloActivo, no reclutando
-
University of Texas at AustinReclutamientoPrediabetes / Diabetes tipo 2Estados Unidos
-
University of SheffieldUniversity of Liverpool; University of Manchester; University of MelbourneActivo, no reclutandoDesarrollo del lenguajeReino Unido
-
Stanford UniversityNational Institute on Aging (NIA)Activo, no reclutandoLa inactividad físicaEstados Unidos
-
Stanford UniversityTerminadoTrastorno autistaEstados Unidos
-
University of MichiganReuben Phoenix Schostak Fontan Wellness Project FundActivo, no reclutandoFragilidad | Fisiología de Fontan | Enfermedad cardíaca de ventrículo únicoEstados Unidos
-
Duke UniversityTerminadoTratamiento y prevención de la anemia después de la administración de la barra nutricional GudnessIndia
-
University of Texas Southwestern Medical CenterAmerican Heart AssociationTerminadoInsuficiencia Cardíaca SistólicaEstados Unidos